节点文献

门静脉区域化疗在预防肝癌切除术后复发中的作用

Role of local chemotherapy through portal vein in preventing tumor recurrence after surgical resection of primary hepatocellular carcinoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈德李悦蒋小峰林景泰薛平胡以则

【Author】 Chen De,Li Yue,Jiang Xiaofeng,et al. Department of Hepatobiliary Surgery,Second Affiliated Hospital of Guangzhou Medical College ,Guangzhou 510182,China

【机构】 广州医学院附属第二医院肝胆外科广州医学院附属第二医院肝胆外科 510260中南大学外科学在职博士研究生510260510260

【摘要】 目的 探讨门静脉区域化疗对原发性肝癌完全切除术后的复发和转移的预防效果。方法  1997年10月至 2 0 0 0年 10月间 ,广州医学院附属第二医院对 4 2例原发肝癌手术切除后分别行肝动脉 (18例 )或门静脉(2 4例 )区域预防性化疗。结果 两组间的术后 1、3、5年总生存率差异无显著意义 (P >0 0 5 ) ,门静脉化疗组的1、3年无瘤生存率显著高于肝动脉化疗组 (P <0 0 5 )。结论 术后门静脉区域预防性化疗可预防和延缓肝癌切除术后的复发和转移。

【Abstract】 Objective To explore the effect of the portal vein local chemotherapy on tumor recurrence after surgical resection of primary hepatic carcinoma.Methods From Oct 1997 to Oct 2000,in Second Affiliated Hospital of Guangzhou Medical College 42 patients with primary hepatocellular carcinoma were performed chemotherapy through hepatic artery(18 cases) or portal vein (24 cases) after surgical tumor resection.Result The total survival rates at 1,3,5 years were no significant difference between the two groups(P>0.05). No-neoplasm survivals rates at 1,3 years in patients of portal vein chemotherapy group were longer than those in patients of the hepatic artery chemotherapy group (P<0.05). Conclusion Local chemotherapy through portal vein was an effective treatment in preventing tumor recurrence and metastasis after surgical resection of primary hepatocellular carcinoma.

【基金】 1999年广东省医学科学技术研究基金项目 (编号A19992 44 )
  • 【文献出处】 中国实用外科杂志 ,Chinese Journal of Practical Surgery , 编辑部邮箱 ,2004年08期
  • 【分类号】R735.7
  • 【被引频次】1
  • 【下载频次】120
节点文献中: 

本文链接的文献网络图示:

本文的引文网络